Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HAO1 | Q9UJM8 | 2/20 | 0.44 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | DNTT | P04053 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4731952 | 1.00 | HAO1 (0.44) | HAO1OR51E2PTPN1ERCC5FEN1 | |
| SCHEMBL380204 | 0.77 | LDHA (0.33) | — | |
| SCHEMBL23361428 | 0.72 | TSHR (0.50) | HAO1OR51E2PTPN1ERCC5FEN1 | |
| SCHEMBL1332598 | 0.72 | TSHR (0.50) | HAO1OR51E2PTPN1ERCC5FEN1 | |
| SCHEMBL891513 | 0.72 | TSHR (0.50) | HAO1OR51E2PTPN1ERCC5FEN1 | |
| SCHEMBL5473789 | 0.70 | — | — | |
| SCHEMBL28089517 | 0.69 | HAO1 (0.45) | HAO1OR51E2PTPN1ERCC5FEN1 | |
| SCHEMBL2440721 | 0.68 | — | — | |
| SCHEMBL11803247 | 0.68 | — | — | |
| SCHEMBL536651 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108350472-A | Process for producing aromatic compound and derivative thereof | 国立研究开发法人理化学研究所 | 2018-07-31 | — | — | CN | claimed |
| CN-1594557-A | Construction and use for gentisic acid 1,2-dioxygenase gene engineering bacterium | CHINA ACADEMY OF SCIENCES WUHA (CN) | 2005-03-16 | — | — | CN | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| CN-112375723-B | Engineering bacteria for producing maleic acid and construction method and application thereof | 北京化工大学 | 2023-06-27 | — | — | CN | disclosed |
| US-20220228190-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-07-21 | — | — | US | disclosed |
| US-11060079-B2 | Methods and microorganisms for producing flavors and fragrance chemicals | ARDRA INC. (CA) | 2021-07-13 | — | — | US | disclosed |
| CN-112375723-A | Engineering bacterium for producing maleic acid and construction method and application thereof | 北京化工大学 | 2021-02-19 | — | — | CN | disclosed |
| US-10329575-B2 | Regulatory sequence for plants | CERES, INC. (US) | 2019-06-25 | — | — | US | disclosed |
| US-20190177713-A1 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | ARDRA INC. (CA) | 2019-06-13 | — | — | US | disclosed |
| EP-3478848-A2 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | Ardra Bio Inc. (US) | 2019-05-08 | — | — | EP | disclosed |
| CN-101974615-A | Method for qualitatively and quantitatively measuring mycothiol | CHINESE ACAD INST MICROBIOLOGY | 2011-02-16 | — | — | CN | disclosed |
| US-20100037355-A1 | SEQUENCE-DETERMINED DNA FRAGMENTS AND CORRESPONDING POLYPEPTIDES ENCODED THEREBY | CERES, INC (US) | 2010-02-11 | — | — | US | disclosed |
| US-20090265815-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded therapy | ALEXANDROV NICKOLAI | 2009-10-22 | — | — | US | disclosed |
| US-20070214517-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | CERES, INC. (US) | 2007-09-13 | — | — | US | disclosed |
| US-20060150283-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | ALEXANDROV NICKOLAI | 2006-07-06 | — | — | US | disclosed |
| US-20060048240-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | ALEXANDROV NICKOLAI | 2006-03-02 | — | — | US | disclosed |
| CN-1594557-A | Construction and use for gentisic acid 1,2-dioxygenase gene engineering bacterium | CHINA ACADEMY OF SCIENCES WUHA (CN) | 2005-03-16 | — | — | CN | disclosed |
| US-6594587-B2 | Determination of associations among set of biological elements using algorithm that is capable of generating Steiner tree | MONSANTO TECHNOLOGY LLC | 2003-07-15 | — | — | US | disclosed |
| US-20020123847-A1 | Method for analyzing biological elements | TELEPHONICS CORPORATION | 2002-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070214517-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | RNGTT, CPSF1, CPSF6 | HAO1 4100/4885OR51E2 2604/4885PTPN1 4727/4885 |
| US-20100037355-A1 | SEQUENCE-DETERMINED DNA FRAGMENTS AND CORRESPONDING POLYPEPTIDES ENCODED THEREBY | RNGTT, CPSF1, CPSF6 | HAO1 4100/4885OR51E2 2604/4885PTPN1 4727/4885 |
| US-20060048240-A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby | RNGTT, CPSF1, CPSF6 | HAO1 4100/4885OR51E2 2604/4885PTPN1 4727/4885 |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | HAO1 4531/4885OR51E2 2730/4885PTPN1 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.